Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Retatrutide is an investigational triple receptor agonist that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Dose-dependent effect: Gastrointestinal side effects, including diarrhea, are generally dose-dependent, meaning the higher the dose, the more likely you are to experience them
Figure 2 depicts the amino acid sequence of tirzepatide in comparison to GLP-1, GIP as well as the GLP-1RA exendin-4 (exenatide)
Aetna cut coverage for Zepbound on July 1, 2025
However, unlike Mounjaro, which targets both GIP and GLP-1 receptors, Semaglutide focuses solely on the GLP-1 receptor
Theyll likely want to discuss how well youve tolerated semaglutide, your weight loss progress, and whether youre meeting your health goals
US$ 26.47
US$ 29.49
US$ 28.95
US$ 28.49
US$ 24.80
US$ 20.31
US$ 28.81
